If Both Parents Are Rh Positive, Can a Child Be Negative?

Two Rh-positive parents can absolutely have an Rh-negative child. This happens when both parents carry a silent copy of the gene variant responsible for Rh negativity and the child inherits that silent copy from each of them. The scenario is common enough that blood banks, obstetricians, and genetic counselors encounter it regularly, yet it still catches many families off guard and occasionally triggers unfounded suspicions about parentage.

How Two Rh-Positive Parents Produce an Rh-Negative Child

Your Rh status depends on whether your red blood cells display a protein called the D antigen. If the protein is present, you are Rh-positive; if it is absent, you are Rh-negative. You inherit two copies of the relevant gene region, one from each parent. A person who has one working copy and one non-working copy still produces enough D antigen to test positive. That person is a carrier of the Rh-negative trait without showing it.

When two carriers have a child together, there is roughly a one-in-four chance that the child inherits the non-working copy from both sides and ends up Rh-negative. The other three-in-four outcomes produce a child who is Rh-positive, either with two working copies or as a carrier like the parents. Because the Rh-positive result is what shows up on a standard blood test, neither parent would have any reason to know they are carriers until an Rh-negative child arrives.

How Common Are Rh-Negative Carriers?

The frequency of Rh negativity varies dramatically across populations, and the carrier rate tracks with it. Among people of European descent, roughly 15 percent are Rh-negative, which means the underlying non-working allele is common enough that a large share of Rh-positive Europeans are carriers. In East Asian populations such as Japanese and Burmese groups, the Rh-positive rate approaches 99 to 100 percent, so carriers are rare and an Rh-negative child from two Rh-positive parents is an unusual event.¹ In India, about 94 percent of the population is Rh-positive, and in Ghana a systematic review found the figure at about 92 percent.²

The practical upshot is that in populations where Rh negativity is relatively common, a surprisingly large chunk of Rh-positive individuals are carriers. If 15 percent of a population is Rh-negative, simple math means that close to half of the Rh-positive individuals in that group carry one silent copy. Two such carriers meeting is far from rare, which is why Rh-negative children from Rh-positive parents are a routine occurrence in European-descent populations and in any community with meaningful Rh-negative frequency.

What Actually Happens at the Gene Level

In most people of European ancestry, Rh negativity results from a wholesale deletion of the RHD gene. The gene is simply missing from both chromosomes, so no D antigen gets made. Research on this deletion showed it occurs within a specific stretch of DNA called the Rhesus box, and the deletion allele has a frequency of about 40 percent among European-associated haplotypes.³ That 40 percent figure refers to the frequency of the allele itself across all chromosomes sampled, not the percentage of people who are Rh-negative. Because you need two copies of the deletion to test negative, the population frequency of the Rh-negative trait is lower than the allele frequency.

The picture is different in people of African descent. Only about 18 percent of Rh-negative Black Africans in one large study completely lacked the RHD gene. The majority, roughly 66 percent, carried something called the RHD pseudogene, which is a copy of the gene that has a small insertion and stop signals that prevent it from producing a functional protein.⁴ Another 15 percent carried a hybrid gene arrangement that also yields a D-negative result.⁵ These molecular differences do not change the inheritance pattern for the average person, but they matter for blood-bank screening and prenatal testing, because some DNA-based tests look specifically for the gene deletion and can miss the pseudogene form.

Weak D and Other Typing Surprises

Rh status is usually presented as a clean positive-or-negative result, but there is a gray zone. Some people carry altered versions of the RHD gene that produce a D antigen in reduced amounts (called weak D) or with a slightly different structure (called partial D). These variants can cause the same person to test positive with one lab’s reagents and negative with another’s.⁶

When discrepant samples were evaluated using both traditional blood-typing methods and molecular genotyping, a study found concordance in only about 65 percent of cases, well below the 80 percent threshold considered clinically acceptable.⁷ Molecular testing resolved the ambiguities by identifying the exact gene variant present.⁸

This matters for the question of “can two positives make a negative” in a less obvious way. A parent with a weak D variant might have been typed as Rh-positive in one context and Rh-negative in another. If both parents happen to carry borderline variants, the child’s result could look unexpected depending on which test was used and when. In these edge cases, molecular testing provides the clearest answer.

Why This Matters During Pregnancy

The main reason anyone outside a genetics classroom cares about Rh status is pregnancy. When an Rh-negative woman carries an Rh-positive fetus, small amounts of the baby’s blood can enter her circulation and trigger her immune system to produce antibodies against the D antigen. This sensitization usually does not harm the first pregnancy much, but in a subsequent pregnancy with another Rh-positive fetus, those antibodies can cross the placenta and destroy fetal red blood cells, causing hemolytic disease of the fetus and newborn.⁹

Prevention hinges on giving the mother an injection of Rh immune globulin (commonly known by brand names like RhoGAM), which mops up any fetal D-positive red cells before her immune system can react. Current guidelines recommend this injection around 28 weeks of pregnancy and again within 72 hours after delivery, as well as after any event that could mix maternal and fetal blood, such as a miscarriage or abdominal trauma.⁹ This strategy has been highly effective, reducing sensitization rates to the range of 0 to about 2 percent in at-risk women.¹⁰

The connection to our main question is direct. If two Rh-positive parents have an Rh-negative daughter, she will eventually need to know her status before or during pregnancy, because any Rh-positive partner she has children with could set the stage for Rh incompatibility. Many women first discover they are Rh-negative through routine prenatal blood work, and some are surprised to learn that both of their own parents are Rh-positive.

Prenatal Testing Can Now Identify the Fetus’s Rh Type Early

A development that changes the practical landscape for Rh-negative pregnant women is the ability to determine the fetus’s Rh type from a simple maternal blood draw. Fragments of fetal DNA circulate in the mother’s blood, and modern tests can detect whether the fetal RHD gene is present. The concept was first demonstrated in 1993, and Scandinavian countries were early adopters, integrating it into routine prenatal care.¹¹

Recent U.S. validation studies have shown these tests to be extremely accurate. One study of over 400 Rh-negative pregnant individuals found 100 percent concordance between the cell-free DNA result and newborn serology, with 100 percent sensitivity and 100 percent specificity.¹² A separate large validation found 100 percent sensitivity and over 99 percent specificity, with results available as early as nine weeks of pregnancy.¹³

The benefit is straightforward. If the test shows the fetus is Rh-negative, the mother does not need Rh immune globulin injections at all, sparing her an unnecessary medical intervention and helping conserve a limited supply of the product. If the fetus is Rh-positive, the standard prevention protocol proceeds as usual. For couples where one or both partners might be carriers, this testing adds early certainty about whether Rh incompatibility is even a concern in that particular pregnancy.

Rh Type and Paternity Suspicions

One of the most common misconceptions around Rh inheritance is the idea that an Rh-negative child from two Rh-positive parents somehow signals that the father is not the biological parent. This concern has circulated for generations. Blood grouping tests, including Rh typing, were among the earliest tools used in disputed paternity cases, and their value in that context was well established by the mid-twentieth century.¹⁴ But the logic of exclusion works in only one direction. Blood typing can sometimes prove that a man is not the father (for instance, if the child has a blood type that is impossible given the alleged father’s type). It cannot prove that he is the father, and an Rh-negative child from two Rh-positive parents is perfectly consistent with paternity if both parents are carriers.

Modern DNA paternity tests have made blood-group-based exclusions largely obsolete for legal purposes. But the emotional reaction lingers. If you or someone you know is troubled by this result, the genetics are unambiguous: two Rh-positive carriers will produce an Rh-negative child about 25 percent of the time. No other explanation is needed.

Why Hasn’t Natural Selection Eliminated the Rh-Negative Allele?

Given that Rh incompatibility can harm or kill a fetus, you might wonder why the Rh-negative allele has not been weeded out of the population over thousands of years. Researchers have investigated whether positive natural selection drove the RHD deletion to its current frequency in European populations. A detailed evolutionary genetics study found no evidence that natural selection favored the deletion. Instead, the allele likely rose to intermediate frequency through random genetic drift or founder effects in ancestral European populations.¹⁵

Once the allele reached a middling frequency, the selection pressure against it is actually quite weak. The fitness cost from Rh disease mostly affects later-born children of Rh-negative mothers with Rh-positive partners, a specific scenario that does not apply to every carrier in every generation. Simulations have confirmed that near a frequency of about 50 percent for the deletion allele, the selection acting on it is very small or essentially absent, meaning genetic drift alone can maintain the frequency without any balancing advantage.¹⁵ This is a less dramatic explanation than some popular theories about Rh-negative blood having mysterious survival benefits, but it fits the data better.

What the Rh Protein Actually Does

Discussions of Rh status tend to focus entirely on transfusion and pregnancy, which can leave people wondering whether being Rh-negative has any other health consequence. The Rh proteins sit in the red blood cell membrane and belong to an ancient family of transport proteins found across many species. Research indicates that they play a role in moving ammonia across the cell membrane and contribute to the structural integrity of red blood cells.¹⁶ People who are Rh-negative lack the D protein specifically but still have the closely related RhCE protein, so the membrane complex is not entirely absent. There is no established clinical consequence of being Rh-negative beyond the transfusion and pregnancy considerations already covered. Claims you may encounter online about Rh-negative individuals having different disease susceptibilities or unusual physiological traits are not supported by robust evidence.

Rh-Negative Blood Supply and Transfusion Decisions

Because Rh-negative individuals make up a minority of most populations, Rh-negative blood units are a limited resource in blood banks. Rh-negative red cells can safely be given to either Rh-positive or Rh-negative recipients, making them especially valuable in emergencies when a patient’s type is unknown. Rh-positive cells, by contrast, carry a risk of sensitizing an Rh-negative recipient. Hospital transfusion services put considerable effort into conserving Rh-negative inventory for patients who truly need it, particularly women of childbearing age where sensitization could endanger future pregnancies.¹⁷

For families where two Rh-positive parents have had an Rh-negative child, this supply issue adds a small but real practical consideration. That child, if they ever need a transfusion, ideally receives Rh-negative blood. And if that child is a daughter who may one day become pregnant, avoiding Rh-positive transfusions becomes even more important to prevent the kind of sensitization that Rh immune globulin is designed to prevent. Knowing your child’s Rh status early allows you to make sure it is clearly documented in their medical records.